News
Eli Lilly says new GLP-1 weight loss pill could reach market in 2026
Drugmaker Eli Lilly says after successful results in a phase 3 clinical trial, it expects to submit a GLP-1 weight loss pill for FDA approval by the end of the year. The pill does not produce the same amount of weight loss as injections,
By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 ...
Next-generation weight-loss pills could hit the market in the coming months, with new data raising a key question: Will ...
A recent survey revealed that over 1 in 10 Americans have used a GLP-1 drug for weight loss.Survey results indicated that up ...
A new daily weight loss pill could be available soon – and a recent trial has shown that people taking the drug can shed ...
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...
A new study in mice has found that muscle loss associated with weight loss from GLP-1 medications like Ozempic may not be as ...
Drugmaker Eli Lilly says their oral, daily GLP-1 pill, orforglipron, may offer similar weight loss results as weekly GLP-1 shots.
People enrolled in the military health care benefits program Tricare for Life no longer will be eligible for coverage of ...
Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback